WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: IDEATE IPILIMUMAB DRUG EVALUATION

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on IDEATE IPILIMUMAB DRUG EVALUATION

Mark Identification

Proof of use for IDEATE IPILIMUMAB DRUG EVALUATION

We do not have any records of a proof of use for IDEATE IPILIMUMAB DRUG EVALUATION at this moment.

Click here to add a proof of use for IDEATE IPILIMUMAB DRUG EVALUATION

Possible trademark infringements of IDEATE IPILIMUMAB DRUG EVALUATION

Basic Information about IDEATE IPILIMUMAB DRUG EVALUATION

Serial Number
86337421
Filing Date
15 Jul 2014
Registration Number
4802230
Registration Date
01 Sep 2015
Mark Drawing Code
4

Classifications

Declare the trademark use of IDEATE IPILIMUMAB DRUG EVALUATION on the blockchain with WikiTrademarks.io.

First use of IDEATE IPILIMUMAB DRUG EVALUATION anywhere
IDEATE IPILIMUMAB DRUG EVALUATION was first used on 31 May 2013 for the primary classification of goods and services, international, 042 (Computer, scientific & legal)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
2
International Code
042
US Codes
100; 101

Who owns IDEATE IPILIMUMAB DRUG EVALUATION?

Correspondent

Marilyn F. Kelly
Bristol-Myers Squibb Company
P.O. Box 4000
Trademark Dept., Mailstop D4243

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on IDEATE IPILIMUMAB DRUG EVALUATION